Supplier wants officials to rethink their advice against COVID antiviral

+News

Supplier wants officials to rethink their advice against COVID antiviral

Martin
Johnston
Wuhan coronavirus CDC
Merck Sharp & Dohme New Zealand has spoken out against the removal of official support for use of molnupiravir [Image: CDC]
“It is necessary to have multiple treatment options to suit patients who are at most risk of developing severe disease” The supplier of a COVID-1